IFNA1 and COVID-19: Although coronavirus can evade and inhibit the IFN response to achieve high pathogenicity [39,40,41,42,43], much evidence has shown that IFN-I and IFN-III still have the potential to treat SARS, MERS, and COVID-19 [44,45,46,47,48,49,50].